Effects of Aging and Liver Disease upon the Pharmacokinetics of Nipradilol

By Aramaki T.  

Clinical Drug Investigation, Vol. 16, Iss. 3, 1998-09 ,pp. : 251-257

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Opioids in Liver Disease

By Tegeder I.   Lötsch J.   Geisslinger G.  

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 17-40

Adis International

Access to resources Recommend Favorite

Cholestasis and Endogenous Opioids: Liver Disease and Exogenous Opioid Pharmacokinetics

By Davis Mellar  

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update

By Palatini Pietro   Orlando Rocco   De Martin Sara  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1215-1230

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Haloperidol: An Update

By Kudo S.  

Clinical Pharmacokinetics, Vol. 37, Iss. 6, 1999-12 ,pp. : 435-456

Adis International

Access to resources Recommend Favorite